Surface Oncology, Inc.

CIK 1718108 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Surface Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Sep 18, 202315-12G0001193125-23-236303
Sep 12, 2023EFFECT9999999995-23-002629
Sep 12, 2023EFFECT9999999995-23-002628
Sep 8, 2023S-8 POS0001193125-23-231530
Sep 8, 202325-NSE0001354457-23-000642
Sep 8, 202340001209191-23-048758
Sep 8, 2023S-8 POS0001193125-23-231539
Sep 8, 2023POS AM0001193125-23-231522
Sep 8, 202340001209191-23-048755
Sep 8, 202340001209191-23-048765
Sep 8, 2023S-8 POS0001193125-23-231534
Sep 8, 202340001209191-23-048764
Sep 8, 2023S-8 POS0001193125-23-231535
Sep 8, 202340001209191-23-048760
Sep 8, 2023POS AM0001193125-23-231521
Sep 8, 2023S-8 POS0001193125-23-231542
Sep 8, 2023S-8 POS0001193125-23-231544
Sep 8, 202340001209191-23-048761
Sep 8, 202340001209191-23-048757
Sep 8, 202340001209191-23-048754
Sep 8, 202340001209191-23-048762
Sep 8, 20238-K0001193125-23-231197
Aug 31, 2023DEFA14A0001193125-23-226416
Aug 30, 2023DEFA14A0001193125-23-224971
Aug 30, 20238-K0001193125-23-224961